{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T11:45:34Z","timestamp":1648899934018},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T00:00:00Z","timestamp":1377043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s10557-013-6480-y","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T07:00:15Z","timestamp":1376982015000},"page":"549-558","source":"Crossref","is-referenced-by-count":2,"title":["Aspirin Dose Increase from 75 to 150 mg Suppresses Red Blood Cell Contribution to Suboptimal Platelet Response to Aspirin in Patients with CAD"],"prefix":"10.1007","volume":"27","author":[{"given":"Kamil","family":"Karolczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Pietruszynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Drzewoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Kasznicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cezary","family":"Watala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,21]]},"reference":[{"key":"6480_CR1","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1046\/j.1538-7836.2003.00284.x","volume":"1","author":"C Patrono","year":"2003","unstructured":"Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs. J Thromb Haemost. 2003;1:1710\u20133.","journal-title":"J Thromb Haemost"},{"key":"6480_CR2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00109-004-0600-x","volume":"83","author":"C Watala","year":"2005","unstructured":"Watala C, Pluta J, Golanski J, Rozalski M, Czyz M, Trojanowski Z, et al. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin. J Mol Med (Berl). 2005;83:148\u201358.","journal-title":"J Mol Med (Berl)"},{"key":"6480_CR3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2011.02.026","volume":"658","author":"B Luzak","year":"2011","unstructured":"Luzak B, Boncler M, Rywaniak J, Wilk R, Stanczyk L, Czyz M, et al. The effect of a platelet cholesterol modulation on the acetylsalicylic acid-mediated blood platelet inhibition in hypercholesterolemic patients. Eur J Pharmacol. 2011;658:91\u20137.","journal-title":"Eur J Pharmacol"},{"key":"6480_CR4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1742-7843.2006.pto_343.x","volume":"98","author":"L Markuszewski","year":"2006","unstructured":"Markuszewski L, Rosiak M, Golanski J, Rysz J, Spychalska M, Watala C. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? Basic Clin Pharmacol Toxicol. 2006;98:503\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"6480_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phrs.2013.04.010","volume":"74C","author":"K Karolczak","year":"2013","unstructured":"Karolczak K, Kamysz W, Drzewoski J, Watala C. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study. Pharmacol Res. 2013;74C:7\u201322.","journal-title":"Pharmacol Res"},{"key":"6480_CR6","doi-asserted-by":"crossref","first-page":"34820","DOI":"10.1074\/jbc.M111.267161","volume":"286","author":"G Zhou","year":"2011","unstructured":"Zhou G, Marathe GK, Willard B, McIntyre TM. Intracellular erythrocyte platelet-activating factor acetylhydrolase I inactivates aspirin in blood. J Biol Chem. 2011;286:34820\u20139.","journal-title":"J Biol Chem"},{"key":"6480_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2003.12.016","volume":"113","author":"C Watala","year":"2004","unstructured":"Watala C, Golanski J, Pluta J, Boncler M, Rozalski M, Luzak B, et al. Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control. Thromb Res. 2004;113:101\u201313.","journal-title":"Thromb Res"},{"key":"6480_CR8","volume-title":"Biostatistical analysis","author":"J Zar","year":"1999","unstructured":"Zar J. Biostatistical analysis. N. J.: Prentice-Hall International, Inc., Simon & Schuster\/A Viacom Company; 1999."},{"key":"6480_CR9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biopha.2007.07.002","volume":"62","author":"M Nocun","year":"2008","unstructured":"Nocun M, Ulicna O, Muchova J, Durackova Z, Watala C. French maritime pine bark extract Pycnogenol reduces thromboxane generation in blood from diabetic male rats. Biomed Pharmacother. 2008;62:168\u201372.","journal-title":"Biomed Pharmacother"},{"key":"6480_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbagen.2005.11.018","volume":"1760","author":"P Gresner","year":"2006","unstructured":"Gresner P, Dolnik M, Waczulikova I, Bryszewska M, Sikurova L, Watala C. Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients: a role of plasma esterases. Biochim Biophys Acta. 2006;1760:207\u201315.","journal-title":"Biochim Biophys Acta"},{"key":"6480_CR11","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2006; 106."},{"key":"6480_CR12","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","volume":"97","author":"L Berglund","year":"2012","unstructured":"Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2969\u201389.","journal-title":"J Clin Endocrinol Metab"},{"key":"6480_CR13","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","volume":"28","author":"I Graham","year":"2007","unstructured":"Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375\u2013414.","journal-title":"Eur Heart J"},{"key":"6480_CR14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","volume":"109","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433\u20138.","journal-title":"Circulation"},{"key":"6480_CR15","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837\u201347.","journal-title":"Circulation"},{"key":"6480_CR16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/CIRCINTERVENTIONS.111.961847","volume":"4","author":"KP Bliden","year":"2011","unstructured":"Bliden KP, Tantry US, DiChiara J, Gurbel PA. Further ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes. Circ Cardiovasc Interv. 2011;4:118\u201320.","journal-title":"Circ Cardiovasc Interv"},{"key":"6480_CR17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCINTERVENTIONS.110.960187","volume":"4","author":"D Capodanno","year":"2011","unstructured":"Capodanno D, Patel A, Dharmashankar K, et al. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease. Circ Cardiovasc Interv. 2011;4:180\u20137.","journal-title":"Circ Cardiovasc Interv"},{"key":"6480_CR18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ahj.2012.06.008","volume":"164","author":"JG Dillinger","year":"2012","unstructured":"Dillinger JG, Drissa A, Sideris G, SC B d, Voicu S, Manzo SS, et al. Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease. Am Heart J. 2012;164:600\u20136.","journal-title":"Am Heart J"},{"key":"6480_CR19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1160\/TH10-02-0082","volume":"105","author":"P Henry","year":"2011","unstructured":"Henry P, Vermillet A, Boval B, Guyetand C, Petroni T, Dillinger JG, et al. 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease. Thromb Haemost. 2011;105:336\u201344.","journal-title":"Thromb Haemost"},{"key":"6480_CR20","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/CIRCULATIONAHA.106.675587","volume":"115","author":"PA Gurbel","year":"2007","unstructured":"Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, et al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation. 2007;115:3156\u201364.","journal-title":"Circulation"},{"key":"6480_CR21","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1161\/CIRCULATIONAHA.111.085464","volume":"125","author":"JL Reny","year":"2012","unstructured":"Reny JL, Berdague P, Poncet A, Barazer I, Nolli S, Fabbro-Peray P, et al. Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study. Circulation. 2012;125:3201\u201310.","journal-title":"Circulation"},{"key":"6480_CR22","first-page":"569","volume":"125","author":"DY Cho","year":"2012","unstructured":"Cho DY, Kim KN, Kim KM, Lee DJ, Kim BT. Combination of high-sensitivity C-reactive protein and homocysteine may predict an increased risk of coronary artery disease in Korean population. Chin Med J (Engl). 2012;125:569\u201373.","journal-title":"Chin Med J (Engl)"},{"key":"6480_CR23","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archsurg.142.11.1066","volume":"142","author":"PS Mullenix","year":"2007","unstructured":"Mullenix PS, Steele SR, Martin MJ, Starnes BW, Andersen CA. C-reactive protein level and traditional vascular risk factors in the prediction of carotid stenosis. Arch Surg. 2007;142:1066\u201371.","journal-title":"Arch Surg"},{"key":"6480_CR24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5551\/jat.6288","volume":"18","author":"S Kameda","year":"2011","unstructured":"Kameda S, Sakata T, Kokubo Y, Mitsuguro M, Okamoto A, Sano M, et al. Association of platelet aggregation with lipid levels in the Japanese population: the Suita study. J Atheroscler Thromb. 2011;18:560\u20137.","journal-title":"J Atheroscler Thromb"},{"key":"6480_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1155\/2008\/371314","volume":"24","author":"H Huang","year":"2008","unstructured":"Huang H, Mai W, Liu D, Hao Y, Tao J, Dong Y. The oxidation ratio of LDL: a predictor for coronary artery disease. Dis Markers. 2008;24:341\u20139.","journal-title":"Dis Markers"},{"key":"6480_CR26","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2001-12-0349","volume":"100","author":"JL Spivak","year":"2002","unstructured":"Spivak JL. Polycythemia vera: myths, mechanisms, and management. Blood. 2002;100:4272\u201390.","journal-title":"Blood"},{"key":"6480_CR27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1208500","volume":"368","author":"R Marchioli","year":"2013","unstructured":"Marchioli R, Finazzi G, Specchia G, et al. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med. 2013;368:22\u201333.","journal-title":"N Engl J Med"},{"key":"6480_CR28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2141.2006.06430.x","volume":"136","author":"M Nisio Di","year":"2007","unstructured":"Di Nisio M, Barbui T, Di Gennaro L, Borrelli G, Finazzi G, Landolfi R, et al. The haematocrit and platelet target in polycythemia vera. Br J Haematol. 2007;136:249\u201359.","journal-title":"Br J Haematol"},{"key":"6480_CR29","first-page":"226","volume":"36","author":"MA Merchant","year":"2004","unstructured":"Merchant MA, Modi DN. Acute and chronic effects of aspirin on hematological parameters and hepatic ferritin expression in mice. Indian J Pharmacol. 2004;36:226\u201330.","journal-title":"Indian J Pharmacol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-013-6480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-013-6480-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-013-6480-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:28:17Z","timestamp":1559237297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-013-6480-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,21]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["6480"],"URL":"https:\/\/doi.org\/10.1007\/s10557-013-6480-y","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,21]]}}}